» Articles » PMID: 29170827

The Role of Nanomaterials in Cell Delivery Systems

Overview
Journal Med Mol Morphol
Publisher Springer
Date 2017 Nov 25
PMID 29170827
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In more than one decade, cell transplantation has created an important strategy to treat a wide variety of diseases characterized by tissue and cell dysfunctions. In this course of action, cell delivery to target site has been always one of the most important constraints and complications, as only a small proportion of the cells are housed in the target sites. Nanotechnology and nanoscale biomaterials have been helpful for cell transplantation in various fields of regenerative medicine including diagnosis, delivery systems for the cell, drug or gene, and cells protection system. In this study, the basic concepts and recently studied aspects of cell delivery systems based on nanoscale biomaterials for transplantation and clinical applications are highlighted. Nanomaterials may be used in combination with cell therapy to control the release of drugs or special factors of engineered cells after transplantation.

Citing Articles

Advancing Tissue Damage Repair in Geriatric Diseases: Prospects of Combining Stem Cell-Derived Exosomes with Hydrogels.

Shi L, Zhou Y, Yin Y, Zhang J, Chen K, Liu S Int J Nanomedicine. 2024; 19:3773-3804.

PMID: 38708181 PMC: 11068057. DOI: 10.2147/IJN.S456268.


Nanomaterials in Medicine: Understanding Cellular Uptake, Localization, and Retention for Enhanced Disease Diagnosis and Therapy.

Peng Y, Yang Z, Sun H, Li J, Lan X, Liu S Aging Dis. 2024; .

PMID: 38421835 PMC: 11745437. DOI: 10.14336/AD.2024.0206-1.


Prospects and Challenges of Electrospun Cell and Drug Delivery Vehicles to Correct Urethral Stricture.

Farzamfar S, Elia E, Chabaud S, Naji M, Bolduc S Int J Mol Sci. 2022; 23(18).

PMID: 36142432 PMC: 9502833. DOI: 10.3390/ijms231810519.


Exosome derived from stem cell: A promising therapeutics for wound healing.

Lv H, Liu H, Sun T, Wang H, Zhang X, Xu W Front Pharmacol. 2022; 13:957771.

PMID: 36003496 PMC: 9395204. DOI: 10.3389/fphar.2022.957771.


Cell Therapy: Types, Regulation, and Clinical Benefits.

El-Kadiry A, Rafei M, Shammaa R Front Med (Lausanne). 2021; 8:756029.

PMID: 34881261 PMC: 8645794. DOI: 10.3389/fmed.2021.756029.


References
1.
Yoo H, Kim T, Park T . Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev. 2009; 61(12):1033-42. DOI: 10.1016/j.addr.2009.07.007. View

2.
Chin B, Nakamoto Y, Bulte J, Pittenger M, Wahl R, Kraitchman D . 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun. 2003; 24(11):1149-54. DOI: 10.1097/00006231-200311000-00005. View

3.
Hosseinzadeh S, Soleimani M, Vossoughi M, Ranjbarvan P, Hamedi S, Zamanlui S . Study of epithelial differentiation and protein expression of keratinocyte-mesenchyme stem cell co-cultivation on electrospun nylon/B. vulgaris extract composite scaffold. Mater Sci Eng C Mater Biol Appl. 2017; 75:653-662. DOI: 10.1016/j.msec.2017.02.101. View

4.
Lin Y, Yeh M, Yang Y, Tsai D, Chu T, Shih Y . Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation. 2010; 122(11 Suppl):S132-41. DOI: 10.1161/CIRCULATIONAHA.110.939512. View

5.
Hale S, Dai W, Dow J, Kloner R . Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment. Life Sci. 2008; 83(13-14):511-5. PMC: 2582905. DOI: 10.1016/j.lfs.2008.07.020. View